Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

<p><strong>Objectives</strong> The Heart Protection Study (HPS) provides an opportunity to assess directly the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial infarction, coronary death, stroke, or revascularization) in patients with peripher...

Täydet tiedot

Bibliografiset tiedot
Päätekijä: Heart Protection Study Collaborative Group
Muut tekijät: The Society for Vascular Surgery
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: Elsevier 2007
Aiheet:

Samankaltaisia teoksia